Midlife lipid changes found more related to the menopause than to ageing

March 2010
Menopause International;Mar2010, Vol. 16 Issue 1, p2
Academic Journal
The article focuses on a report from the Study of Women's Health Across the Nation (SWAN) released in the U.S. in 2010, revealing the impact of menopause on midlife lipid changes. It could not be confirmed whether menopause had an impact on a woman's risk of cardiovascular disease but the SWAN report revealed several menopause-induced changes including an increase in apolipoprotein B, an increase in low-density lipoprotein cholesterol, and an increase in total cholesterol. Such study involved approximately 3,000 American women.


Related Articles

  • Lifetime risk assessment measure for women may have limits. Raible, Eric // Cardiology Today;May2008, Vol. 11 Issue 5, p14 

    The article discusses research being done on the limits of lifetime risk assessment measure for women. It references a study by R. Blumenthal and colleagues, presented at the American College of Cardiology Heart of Women's Health conference in February 2008. Researchers claim that lifetime risk...

  • Preventing CVD in women: updates focus on real-world advice.  // PharmacoEconomics & Outcomes News;3/5/2011, Issue 623, p9 

    The article reports that the American Heart Association (AHA) has updated the "Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women." The updated guidelines covers personal and socioeconomic factors that stop women from sticking to lifestyle and medical recommendations. It...

  • Prevent Disease. Bush, Laura // Personal Excellence Essentials;Oct2004, Vol. 9 Issue 10, p9 

    Focuses on the author's opinion on how to prevent heart diseases in women. List of the things to do to take good care of one's heart; risk brought about by smoking to the heart; Percentage of women who have heart attacks due to obesity.

  • RED alert!  // Westchester County Business Journal;1/31/2005, Vol. 44 Issue 5, special AHA section p4 

    Provides information about the health of women in the United States. Estimated number of women who die of heart disease, stroke and other cardiovascular diseases; Health gap between men and women.

  • What type of exercise prevents cardiovascular disease in postmenopausal women? Rivet, Christine // CMAJ: Canadian Medical Association Journal;2/4/2003, Vol. 168 Issue 3, p314 

    Presents a study to evaluate the effects of walking in the primary prevention of cardiovascular disease in postmenopausal women. Self-administered questionnaires given to postmenopausal women to assess their level of physical activity; Strong dose-response effect found between physical activity...

  • healthy heart. Phelps, Kerryn; Harrison, Samantha // Australian Women's Weekly;May2005, Vol. 75 Issue 5, p161 

    Discusses the risks associated with heart disease in women. Reasons behind the high statistics of women who die from heart failure; Objectives of the Heart Foundation's Heart Week cardiovascular health awareness campaign to be held in Australia in May 2005; Functions of the heart.

  • EXERCISE & MENOPAUSE.  // Body Bulletin;Nov2003, Vol. 4 Issue 11, p3 

    The article focuses on information related to menopause. Most women enter menopause in their early 50's when estrogen levels drop dramatically culminating in the cessation of ovulation and monthly periods. With the declining estrogen they face increased risk of heart disease, bone and muscle...

  • Type A Behavior Pattern, Heart Disease Risk Factors, and Estrogen Replacement Therapy in Postmenopausal Women: The Rancho Bernardo Study. Buller, J.C.; Kritz-Silverstein, Donna; Barrett-Connor, Elizabeth; Wingard, Deborah // Journal of Women's Health;Feb98, Vol. 7 Issue 1, p49 

    Cardiovascular disease is the leading cause of death among older American women. Estrogen replacement therapy (ERT) appears to reduce the risk of heart disease. For nearly five decades, the Type A behavior p alien (TABP) has been implicated in the cardiac morbidity and moretality of both men and...

  • New Warnings On Prempro, Premphase, And Premarin.  // RN;Dec2002, Vol. 65 Issue 12, p97 

    The article reports on the risk associated with Prempro, Premphase, and Premarin, the three popular brands of hormone replacement therapy for postmenopausal women in the U.S. According to the Women's Health Initiative report that these products can increase the risk in breast cancer,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics